
INmune Bio (NASDAQ:INMB) brought in sales totaling $163.00 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 2.25%, resulting in a loss of $9.67 million. In Q3, INmune Bio brought in $14.00 thousand in sales but lost $9.46 million in earnings.